Potential Clinical Applications of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer
10.1007/s13139-016-0446-5
- Author:
Ihn Ho CHO
1
;
Eun Jung KONG
Author Information
1. Department of Nuclear Medicine, Yeugnam University Hospital, 317-1, Daemyung-dong,Nam-gu, Daegu 705-717, Republic of Korea. Ihcho@med.yu.ac.kr
- Publication Type:Review
- Keywords:
PET/MR;
FDG;
Breast cancer;
Staging;
Lymphaticmetastasis;
Attenuation correction
- MeSH:
Breast Neoplasms;
Breast;
Electrons;
Humans;
Magnetic Resonance Imaging;
Mammography;
Metabolism;
Positron-Emission Tomography;
Positron-Emission Tomography and Computed Tomography;
Prone Position
- From:Nuclear Medicine and Molecular Imaging
2017;51(3):217-226
- CountryRepublic of Korea
- Language:English
-
Abstract:
The whole-body positron emission tomography (PET)/magnetic resonance (MR) scan is a cutting edge technology providing comprehensive structural information from MR imaging and functional features from PET in a single session. Recent research findings and clinical experience have shown that ¹⁸F-fluorodeoxyglucose (FDG) whole-body PET/MRimaging has a diagnostic performance comparable with or superior to that of PET/CT in the field of oncology, including for breast cancer. In particular, FDG PET/MR mammography in the prone position with the breast hanging in a pendant manner can provide more comprehensive information about the metabolism, anatomy, and functional features of a breast lesion than a whole-body PET/MR scan. This article reports on current state-of-the-art PET/MR mammography in patients with breast cancer and the prospects for potential application in the future.
